Literature DB >> 19246973

Effect of very low LDL-cholesterol on cortisol synthesis.

K Sezer1, R Emral, D Corapcioglu, R Gen, E Akbay.   

Abstract

BACKGROUND: Cardiovascular disease is the most common cause of mortality around the world. The relationship between coronary artery disease and serum LDL-cholesterol levels has become obvious in recent years and statin treatment has been used more commonly. However, influence of intensive statin treatment on steroidal hormonal functions has remained unclear. In this paper, we evaluated the effect of very low LDL levels (<70 mg/dl) on serum cortisol concentrations, which is mainly synthesized from cholesterol. SUBJECTS AND METHODS: Forty-one patients with serum LDL-cholesterol levels below 70 mg/dl were included in the study. The control group consisted of 38 healthy people. Adrenal axis was evaluated by means of cortisol response to 1 microg ACTH test.
RESULTS: The mean age of patients was 52.45+/-10.74 yr. Of 41 patients, 19 (46.9%) were female. There were statistically significant differences between the study and control group according to their serum cholesterol and LDL levels. Main serum LDL levels were 58+/-11.4 mg/dl and 131+/-25.8 mg/dl in the study and control group, respectively. There were no statistically significant differences in response to 1 microg ACTH stimulation test at basal, 30 min and 60 min among both study and control group. Atorvastatin treatment was generally well tolerated.
CONCLUSIONS: Our data reflect that having serum LDL-cholesterol levels below 70 mg/dl did not affect the adrenal axis function in terms of cortisol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19246973     DOI: 10.1007/BF03345655

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  37 in total

1.  One microgram is the lowest ACTH dose to cause a maximal cortisol response. There is no diurnal variation of cortisol response to submaximal ACTH stimulation.

Authors:  G Dickstein; D Spigel; E Arad; C Shechner
Journal:  Eur J Endocrinol       Date:  1997-08       Impact factor: 6.664

2.  Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads.

Authors:  D Travia; F Tosi; C Negri; G Faccini; P Moghetti; M Muggeo
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

Review 3.  The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands.

Authors:  J T Gwynne; J F Strauss
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

4.  Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin.

Authors:  W H Farnsworth; J M Hoeg; M Maher; E H Brittain; R J Sherins; H B Brewer
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

5.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

6.  B-Type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells.

Authors:  Faquan Liang; Ann M Kapoun; Andrew Lam; Debby L Damm; Diana Quan; Maile O'Connell; Andrew A Protter
Journal:  Endocrinology       Date:  2007-05-03       Impact factor: 4.736

7.  The role of lysine-rich proteins in the acute steroidogenic response of rat adrenal cells to ACTH.

Authors:  B C Mc Namara; G S Boyd
Journal:  Biochem Biophys Res Commun       Date:  1984-01-30       Impact factor: 3.575

8.  Atorvastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia.

Authors:  Stefano A Santini; Cinzia Carrozza; Paola Lulli; Cecilia Zuppi; Gian CarloTonolo; Salvatore Musumeci
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

9.  The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis.

Authors:  J T Gwynne; B Hess
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

10.  Adrenal function in heterozygous and homozygous hypobetalipoproteinemia.

Authors:  D R Illingworth; T A Kenny; E S Orwoll
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

View more
  2 in total

1.  Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".

Authors:  Rene Baudrand; Luminita Pojoga; Anand Vaidya; Amanda Garza; Paul Vöhringer; Xavier Jeunemaitre; Paul Hopkins; Tham Yao; Jonathan Williams; Gail Adler; Gordon Williams
Journal:  Circulation       Date:  2016-04-19       Impact factor: 29.690

2.  Statin discontinuation: counterbalancing the benefits with the potential risks.

Authors:  Kosmas I Paraskevas; Sotirios Koupidis; Fotini Gentimi; Alexandros A Tzovaras
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.